Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Family Care Hospitals Ltd

FAMILYCARE
BSE
3.21
0.62%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Family Care Hospitals Ltd

FAMILYCARE
BSE
3.21
0.62%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
17Cr
Close
Close Price
3.21
Industry
Industry
Hospitals/Medical Services
PE
Price To Earnings
PS
Price To Sales
101.99
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
-98.60%
PAT Gr TTM
PAT Growth TTM
-85.56%
Peer Comparison
How does FAMILYCARE stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
FAMILYCARE
VS

Quarterly Results

Upcoming Results on
2 May 2026
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
1412121144400000
Growth YoY
Revenue Growth YoY%
61.16.19.53.5-69.0-66.7-68.8-99.7-99.5-99.5-98.2100.0
Expenses
ExpensesCr
1110101034-2721041
Operating Profit
Operating ProfitCr
22211031-2-10-4-1
OPM
OPM%
16.119.016.213.122.66.0798.2-5,833.3-5,200.0-1,950.0-6,271.4-1,133.3
Other Income
Other IncomeCr
000120-7402000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
222230-43-21-1-5-1
Tax
TaxCr
1110-60000000
PAT
PATCr
111190-43-21-1-5-1
Growth YoY
PAT Growth YoY%
21.53.1-13.7-5.9560.0-82.8-3,534.1-287.5-88.5-404.489.354.3
NPM
NPM%
9.511.210.19.8202.45.8-1,115.2-7,000.04,950.0-3,500.0-6,585.7-1,600.0
EPS
EPS
0.20.30.30.21.60.0-8.0-0.40.2-0.1-0.8-0.2

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
012514133542424080
Growth
Revenue Growth%
408.51,470.768.0188.6173.5-6.7166.919.0-0.1-4.8-80.2-97.8
Expenses
ExpensesCr
0124131128333433-217
Operating Profit
Operating ProfitCr
000112898728-7
OPM
OPM%
-256.819.514.825.910.216.122.220.519.816.9359.4-3,823.5
Other Income
Other IncomeCr
-25000000013-712
Interest Expense
Interest ExpenseCr
000011100000
Depreciation
DepreciationCr
000011111111
PBT
PBTCr
-25001006778-44-6
Tax
TaxCr
000000222-400
PAT
PATCr
-250010045513-44-5
Growth
PAT Growth%
-7,297.9100.1681.0444.2-97.849.114,214.827.61.1138.7-451.888.0
NPM
NPM%
-36,440.51.98.816.50.10.211.512.412.531.4-558.5-3,105.9
EPS
EPS
-17.60.00.10.30.00.01.21.50.22.3-8.2-1.0

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
323232323232323254545454
Reserves
ReservesCr
-28-28-28-27-27-27-23-18-84-41-46
Current Liabilities
Current LiabilitiesCr
11159552022103236
Non Current Liabilities
Non Current LiabilitiesCr
000007667201
Total Liabilities
Total LiabilitiesCr
556101417204075704646
Current Assets
Current AssetsCr
332036113259554141
Non Current Assets
Non Current AssetsCr
2239101198161454
Total Assets
Total AssetsCr
556101417204075704646

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
00031-142-50-17
Investing Cash Flow
Investing Cash FlowCr
-20-1-5-2-200-201
Financing Cash Flow
Financing Cash FlowCr
501015-5-226-1-1
Net Cash Flow
Net Cash FlowCr
300-201-1019-2-17
Free Cash Flow
Free Cash FlowCr
-20-1-20-441-7-1-17
CFO To PAT
CFO To PAT%
0.31,698.0291.0354.46,348.3-4,532.595.832.4-100.0-3.039.2
CFO To EBITDA
CFO To EBITDA%
38.6163.9172.7226.283.4-60.649.819.6-63.1-5.5-61.0

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
02653590355063613819
Price To Earnings
Price To Earnings
0.0823.0330.068.50.01,100.012.212.111.63.00.0
Price To Sales
Price To Sales
0.024.729.411.40.02.71.41.51.40.92.5
Price To Book
Price To Book
0.06.712.912.00.07.05.54.41.30.71.4
EV To EBITDA
EV To EBITDA
12.4116.7190.944.2-0.120.37.07.85.53.50.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.097.895.494.689.565.264.964.5566.7
OPM
OPM%
-256.819.514.825.910.216.122.220.519.816.9359.4
NPM
NPM%
-36,440.51.98.816.50.10.211.512.412.531.4-558.5
ROCE
ROCE%
-554.40.64.923.010.66.044.240.515.813.7-262.2
ROE
ROE%
-634.10.53.917.30.40.644.936.511.521.5-328.0
ROA
ROA%
-549.60.42.98.70.10.220.013.17.017.9-95.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Family Care Hospitals Limited (FCHL) is an emerging multi-specialty healthcare provider based in the Mumbai Metropolitan Region (MMR), operating under the brands *Family Care Hospitals* and *Scandent Imaging*. The company integrates **physical infrastructure with digital innovation** to deliver accessible, affordable, and comprehensive healthcare services across hospitals, diagnostics, pharmacy, and digital/home-based care. FCHL’s operations are structured into four core verticals: - **Hospitals**: 100-bed NABH-accredited tertiary care facility in Mira Road, Thane - **Imaging**: 9 diagnostic centers under the brand ‘Scandent’ offering dental and ENT imaging via CBCT technology - **Pharmacy**: In-house 24x7 pharmacy integrated with digital platforms - **New Generation Healthcare & Support Services**: Teleconsultations, e-pharmacy, e-pathology, home care, and digital health packages The company serves both **B2C and B2B markets**, with a strategic focus on suburban and underpenetrated areas of Mumbai, Thane, and Western Maharashtra. --- ### **Recent Developments (Jun 2025)** - **Convertible Warrants Issuance**: To ensure operational continuity and avoid litigation, FCHL is issuing **convertible warrants** to settle outstanding vendor liabilities, including those to the promoter group. This move signals financial restructuring efforts amid funding needs. - **Digital-First Platform Expansion**: FCHL is advancing its **digital healthcare platform**, enabling: - Electronic Health Records (EHR) - Online consultations (audio/video) - Digital diagnostics and medicine delivery - Personalized health monitoring for domestic and international users - **Hybrid Care Model**: Establishing local and international entities to support **physical diagnostics and care coordination**, creating a seamless **omnichannel patient experience**. - **Funding Requirement**: Anticipates substantial investment in: - Product development - Marketing & sales - Data/AI infrastructure - Expansion of physical facilities --- ### **Strategic Growth Drivers** #### **1. Geographical & Physical Expansion** - **Mira Road Hospital Expansion**: Ongoing acquisition of land for hospital expansion as part of the Mira Road strategic hub. - **Tier 3 City Focus**: Targeting **rural and semi-urban areas** in Western Maharashtra, leveraging a **lease rental business model** due to existing infrastructure and medical talent availability. - **Portfolio Diversification**: Expanding surgical volumes at existing hospitals and planning **new facility openings** in high-demand areas. #### **2. Digital Transformation & E-Commerce Models** - **Family Care Mobile App & Website**: Offers end-to-end digital services including: - Doctor appointments - e-surgery consultations - Lab test bookings - Medicine ordering and home delivery - Patient record storage - **Bundled Health Packages**: - Sold via **Dealmoney Distribution and E-Marketing Pvt Ltd (DDEPL)**, a related party. - Packages valid for 1–2 years; include unlimited free OPD, audio/video consultations, medicine discounts, reduced test fees, and limited free IPD services (surgery, hospitalization). - **Health Coupons / Membership Model (“Family Care 911 Health Package”)**: - Drives customer acquisition and retention. - Has significantly boosted revenue and patient inflow since FY23. #### **3. Strategic Partnerships & Marketing** - **MOU with DDEPL**: - Agreement for **100,000 patient leads** over 12 months at ₹400/lead (up to ₹4 crore). - Includes social media content, SEO, app optimization, and lead generation. - **Multi-Channel Marketing**: - Combines traditional (print, radio) and digital (social media, SEM) methods. - Health camps and corporate engagement to deepen community outreach. #### **4. Operational Excellence & Financial Optimization** - **Cost Optimization Initiatives**: - Rationalizing drug and consumable costs - Optimizing CapEx and indirect spending - Turnaround of underperforming centers - **EBITDA & ROCE Improvement**: Focused on enhancing profitability and capital efficiency in the Healthcare Services segment. - **Revenue Stream Diversification**: - Diagnostic services benefiting from **home collection, online booking, and fast digital reporting**. - Pharmacy revenue linked primarily to hospital footfall (secondary growth pillar). --- ### **Key Operational Metrics & Historical Context** | Metric | Detail | |-------|--------| | **Hospital Facility** | 100-bed, NABH-accredited hospital in Mira Road, Thane<br>- 21,000–25,000 sq ft<br>- Services: Emergency, ICUs, Cath Lab, Oncology, Cardiology, Neurology, Women & Child Care, etc. | | **Medical Team** | ~135 staff + 60–70+ affiliated consultants across specialties | | **Patient Volume (Historic)** | Over **40,000 patients treated** cumulatively as of Apr 2022<br>- Surgeon >4,000 procedures performed | | **Bed Occupancy (as of Oct 2022)** | Declined to **49.7% (2022)** from 75.4% (2020)<br>- ARPOB increased to ₹11,092 in 2022 from ₹5,135 in 2020 | | **Outpatient Growth** | Tripled from 3,417 (2020) to 11,214 (2022) | | **Imaging Division** | 9 centers under ‘Scandent’ – **largest independent dental/ENT imaging chain in Mumbai**<br>- Utilizes **CBCT technology** for craniofacial diagnostics | | **Revenue Contribution (FY22)** | Hospital division contributed **94.61%** of total revenue | --- ### **Challenges & Risks** - **Single Hospital Dependency**: Heavy reliance on one hospital limits scalability unless new acquisitions or greenfield projects are executed. - **Physician Retention Risk**: Dependent on attracting high-net-worth physicians with strong referral networks; vulnerable to market competition and payment delays. - **Funding Needs**: Ambitious digital and physical expansion requires significant capital, which may strain balance sheet without external funding or equity conversion. - **Bed Occupancy Pressure**: Despite growth in OPD, **inpatient utilization has declined**, suggesting need for improved marketing or specialized service pull.